These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9770737)

  • 1. [A comparison of the hypolipidemic action of probucol at doses of 500 and 1000 mg/day in moderate hyperlipoproteinemia].
    Tvorogova MG; Lupanov VP; Nuraliev EIu; Zaĭtseva TM; Kukharchuk VV; Titov VN
    Ter Arkh; 1998; 70(8):17-21. PubMed ID: 9770737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lipanor treatment of atherogenic hyperlipoproteinemia].
    Susekov AV; Tvorogova MG; Arabidze GG; Kukharchuk VV
    Ter Arkh; 1998; 70(9):57-61. PubMed ID: 9821228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prolonged probucol treatment in patients with cardiovascular diseases (author's transl)].
    Scebat L; Renais J
    Nouv Presse Med; 1980 Oct; 9(40):3008-10. PubMed ID: 7443441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of 1 month's treatment with Bezalip on the serum lipids and lipoproteins of patients with different types of hyperlipoproteinemias].
    Kiriakov A; Malamov E; Apostolova Iu; Tsenov I; Tinterova Z
    Vutr Boles; 1983; 22(3):74-81. PubMed ID: 6649587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Indications for and the therapeutic action of hypolipidemic agents in patients with hyperlipoproteinemias].
    Goranov I; Naumova R; Kerekovska M; Balabanski L
    Vutr Boles; 1987; 26(1):96-101. PubMed ID: 3590738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The characteristics of the hypolipidemic effect of Mevacor with its permanent multiyear use].
    Lipovetskiĭ BM
    Ter Arkh; 1996; 68(12):72-5. PubMed ID: 9054048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of probucol on skin cholesterol concentrations in patients with type II hyperlipoproteineamia (author's transl)].
    Beaumont JL; Jacotot B; Buxtorf JC; Meliço-Silvestre AA; Beaumont V
    Nouv Presse Med; 1980 Oct; 9(40):2995-3000. PubMed ID: 7443438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term administration of probucol and QTc interval prolongation.
    Sasaki N; Saku K; Moroe K; Zhang B; Hirata K; Liu R; Arakawa K
    Artery; 1993; 20(2):115-21. PubMed ID: 8512458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of probucol on cardiac electrophysiology in anginal patients with hyperlipidemia and diabetes mellitus type II].
    Anikin VV; Savin VV; Lupanov VP; Razygraev RA
    Ter Arkh; 2000; 72(8):28-30. PubMed ID: 11019422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Personal experience with the hypolipidemic agent Olbetam-Acipimox in hyperlipoproteinemia associated with type II diabetes].
    Rajecová E; Kréze A; Klimes I; Cvrkalová A; Lacko A; Langrová H; Hanzen E
    Cas Lek Cesk; 1991 Nov; 130(22-23):661-3. PubMed ID: 1786587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma levels of probucol in man after single and repeated oral doses (author's transl)].
    Heeg JF; Tachizawa H
    Nouv Presse Med; 1980 Oct; 9(40):2990-4. PubMed ID: 7443437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypolipidemic and hypouricemic action of fenofibrate in various types of hyperlipoproteinemias.
    Harvengt C; Heller F; Desager JP
    Artery; 1980; 7(1):73-82. PubMed ID: 7247733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal plasma concentrations of plant sterols can predict LDL-C response to sitosterol in patients with familial hypercholesterolemia.
    Fuentes F; López-Miranda J; García A; Pérez-Martínez P; Moreno J; Cofan M; Caballero J; Paniagua JA; Ros E; Pérez-Jiménez F
    Eur J Clin Nutr; 2008 Apr; 62(4):495-501. PubMed ID: 17440528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of the multicenter controlled study of the hypolipidemic drug polycosanol in Russia].
    Nikitin IuP; Slepchenko NV; Gratsianskiĭ NA; Nechaev AS; Syrkin AL; Poltavskaia MG; Sumarokov AV; Revazov AV
    Ter Arkh; 2000; 72(12):7-10. PubMed ID: 11201841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of L-carnitine on plasma lipoprotein fatty acids pattern in patients with primary hyperlipoproteinemia.
    Stefanutti C; Vivenzio A; Lucani G; Di Giacomo S; Lucani E
    Clin Ter; 1998; 149(2):115-9. PubMed ID: 9780475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of probucol on the cholesterol content of skin in type II hyperlipoproteinemias.
    Beaumont JL; Jacotot B; Buxtorf JC; Silvestre M; Beaumont V
    Artery; 1982; 10(1):71-87. PubMed ID: 7092577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.
    Castaño G; Mas R; Fernández L; Illnait J; Gámez R; Alvarez E
    Int J Clin Pharmacol Res; 2001; 21(1):43-57. PubMed ID: 11708574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of micronised fenofibrate in a randomised double-blind study comparing four doses from 200 mg to 400 mg daily with placebo in patients with hypercholesterolemia.
    Krempf M; Rohmer V; Farnier M; Issa-Sayegh M; Corda C; Sirugue I; Gerlinger C; Masseyeff-Elbaz MF
    Diabetes Metab; 2000 May; 26(3):184-91. PubMed ID: 10880891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A trial of the use of the hypolipidemic preparation Lipanor (ciprofibrate) in patients with primary hyperlipidemia].
    Kukharchuk VV; Rozhkova TA; Kotova LA; Tvorogova MG; Semenova OA
    Ter Arkh; 1996; 68(6):58-61. PubMed ID: 8771689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.